Stoke Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.01x
Net debt / equity: -0.39x
Debt / assets: 0.01x
Debt / EBITDA: -0.02x
Net debt / EBITDA: 0.93x

Liquidity & coverage

Current ratio: 8.99x
Quick ratio: 8.99x
Cash ratio: 8.42x
Interest coverage: -54.39x
EBITDA / interest: -48.18x
Working capital: $325.9M

Cash & dividend

FCF / debt: -43.15x
Cash flow / debt: -42.89x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.